U.S. Markets open in 3 hrs 59 mins

NanoVibronix, Inc. (NAOV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7500-0.0100 (-1.32%)
At close: 4:00PM EST

0.7200 -0.03 (-4.00%)
Before hours: 5:07AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7600
Open0.8000
Bid0.0000 x 3100
Ask0.7900 x 2200
Day's Range0.7006 - 0.8399
52 Week Range0.5350 - 3.5000
Volume3,615,024
Avg. Volume4,402,800
Market Cap10.045M
Beta (5Y Monthly)-0.39
PE Ratio (TTM)N/A
EPS (TTM)-0.6140
Earnings DateNov 16, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    NanoVibronix Reports Third Quarter 2020 Financial Results, Provides Business Update

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today reported its financial results for the quarter ended September 30, 2020 and provided a business update.

  • NanoVibronix Expands Offerings with Introduction of PainShield Plus®
    Business Wire

    NanoVibronix Expands Offerings with Introduction of PainShield Plus®

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the launch of the next generation of its ultrasound pain management device, PainShield Plus® for the treatment of multiple areas of pain in tandem.

  • Business Wire

    NanoVibronix Receives Positive Nasdaq Listing Determination

    NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Company has received formal notification that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Capital Market pursuant to an extension through December 15, 2020, to evidence compliance with the minimum $2.5 million stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b) for continued listing on The Nasdaq Capital Market (the "Rule").